#MASLD
LightNews LightNews
natrevgastrohep.nature.com
ICYMI: New online! Gut fungi linked to development of MASLD-HCC
Gut fungi linked to development of MASLD-HCC
Nature Reviews Gastroenterology & Hepatology, Published online: 27 October 2026; doi:10.1038/s41575-026-01273-xGut fungi linked to development of MASLD-HCC
dlvr.it
November 2, 2026 at 6:02 PM
natrevgastrohep.nature.com
ICYMI: New online! Gut fungi linked to development of MASLD-HCC
Gut fungi linked to development of MASLD-HCC
Nature Reviews Gastroenterology & Hepatology, Published online: 27 October 2026; doi:10.1038/s41575-026-01273-xGut fungi linked to development of MASLD-HCC
dlvr.it
October 28, 2026 at 6:01 PM
scinews.bsky.social
Greater adherence to the Planetary Health Diet (PHD 2.0) is associated with a decreased risk of MASLD as well as favorable magnetic resonance imaging biomarkers.

Open access
doi.org/10.59717/j.x...
November 1, 2026 at 3:17 PM
natrevgastrohep.nature.com
New online! Gut fungi linked to development of MASLD-HCC
Gut fungi linked to development of MASLD-HCC
Nature Reviews Gastroenterology & Hepatology, Published online: 27 October 2026; doi:10.1038/s41575-026-01273-xGut fungi linked to development of MASLD-HCC
dlvr.it
October 27, 2026 at 6:01 PM
brainimmunity.bsky.social
University of California Riverside School of Medicine (Biomed.ucr.edu) is seeking to hire tenured Assoc or Full Professors with research programs in cardiometabolic diseases, including cardiovascular disease, type 2 diabetes, obesity, MASLD. Apply by 12/11
aprecruit.ucr.edu/JPF02370
#academicsky
School of Medicine Division of Biomedical Sciences
Bridging the gap between science research & clinical medicine
Biomed.ucr.edu
November 1, 2026 at 12:27 AM
thelancetendo.bsky.social
The ongoing global epidemic of #MASLD & its close pathogenic & predictive relationship with the non-communicable diseases of #cardiovascular disease, #cancer, #obesity, & type 2 #diabetes, allow the inclusion of MASLD as a new non-communicable disease www.thelancet.com/journals/lan...
#OpenAccess
In patients with MASLD with a strong hepatic genetic component, hepatic lipid content is high but insulin resistance, adiposity, and the risk of type 2 diabetes are not. The risk of cardiovascular disease is associated with the severity of obesity. The risk of MASH and fibrosis is moderate to strongly increased in patients with MASLD with a strong hepatic genetic component. In patients with MASLD with a strong metabolic component related to hepatic de novo lipogenesis (ie, high intake of glucose, diabetes-associated hyperinsulinaemia, and hyperglycaemia), often increased insulin resistance and adiposity, severe dyslipidaemia, hyperglycaemia, and an increased risk of cardiovascular disease are observed. In patients with MASLD with a strong metabolic component related to adipose tissue dysfunction (ie, lipodystrophy, high amount of visceral fat and low amount of gluteofemoral fat, adipose tissue with insulin resistance, increased lipolysis, inflammation, and dysregulated adipokines) a high prevalence of insulin resistance, type 2 diabetes, and cardiovascular disease, but a low amount of adiposity and moderate dyslipidaemia are observed. Both MASLD phenotypes with a strong metabolic component have a moderately increased risk of MASH and fibrosis. MASH=metabolic dysfunction-associated steatohepatitis. MASLD=metabolic dysfunction-associated steatotic liver disease. ↑=moderate increase. ↓=moderate decrease. ↑↑=strong increase. ↑↑↑=very strong increase of prevalence or risk of disease. –= no change of prevalence or risk of disease. *Variability in PNPLA3 and TM6SF2 are associated with decreased risk of cardiovascular disease.
October 30, 2026 at 6:00 PM
liversmdpi.bsky.social
📢 Highly Cited Paper in #LiversMDPI

🧬 Abdelhameed et al. review gut microbiota in MASLD pathogenesis

🩺 Microbiome signatures offer promise as non-invasive diagnostic biomarkers

📖 Read More: www.mdpi.com/2673-4389/5/...

#MASLD #GutMicrobiota #Liver
October 29, 2026 at 1:35 AM
aga-cgh.bsky.social
Episodic heavy drinking is prevalent in MASLD and associated with a 3-fold higher odds of advanced liver fibrosis compared to individuals with MASLD without episodic heavy drinking. Read more here! ⬇️

🔗: https://ow.ly/ykfQ5101Jrh
November 2, 2026 at 2:00 PM
diabetologiajnl.bsky.social
Our Nov cover shines the light on people with #MASLD & #diabetes. The geometric, interconnected design reflects the complexity of inter-organ crosstalk & its dysregulation in these conditions diabetologia-journal.org/collections/... Credit: Nayere Taebnia, KI
November 2, 2026 at 1:13 PM
aga-cgh.bsky.social
🤰 What does MASLD mean for pregnancy? The Fatty Liver in Pregnancy (FLIP) study evaluated 1,100+ women, finding 87% with steatosis on imaging met MASLD criteria and identifying novel links with adverse maternal & neonatal outcomes. 🔬 @tatyanakushner

🔗: https://ow.ly/1pjA5101IjZ
October 28, 2026 at 6:00 PM
liversmdpi.bsky.social
📢 Highly Cited Paper in #LiversMDPI

🧬 Prasoppokakorn reviews statins in MASLD.

🩺 The review examines effects on liver enzymes, inflammation, and fibrosis.

📖 Read More: www.mdpi.com/2673-4389/5/...

#MASLD #Statins #liverdisease
October 30, 2026 at 9:13 AM
kathrynmarycrowley.bsky.social
Living with MASLD? If you are based in any of Ireland's northern counties, please get in touch via my website (should you wish to share some of your story). My piece will address stigma and inform readers. #MASLD #Belfast #journorequest #liverhealth @liveruk.bsky.social #pathsky #liversky
Cartoon of a liver with an umbrella over it. Text reads 'Global Think-tank on Steatotic Liver Disease.' The sticker was shared at the World Health Summit 2026 following sessions on liver disease.
October 29, 2026 at 3:43 PM
aga-ghadvances.bsky.social
Dietary fiber boosts gut microbiome-derived glycine lipids. These molecules reach the liver, enhance mitochondrial health, and protect against fatty liver disease (MASLD).
🔗 https://ow.ly/SARC51018Nt
October 28, 2026 at 4:00 PM
bibliotecahuvh.bsky.social
Pharmacotherapy for MASLD: current evidence and challenges in clinical practice www.sciencedirect.com/science/arti... #hvhebron #hepato [Text complet]
Pharmacotherapy for MASLD: current evidence and challenges in clinical practice
Metabolic dysfunction–associated steatotic liver disease (MASLD) is characterized by a complex pathophysiology driven by intertwined metabolic and hep…
www.sciencedirect.com
October 28, 2026 at 9:57 AM
diabetologiajnl.bsky.social
How has newly diagnosed #Type2Diabetes evolved? A 180k+ cohort over 15 years: older, multimorbid, #MASLD surge, yet better glycaemic management. Uptake of #SGLT2i and #GLP1RA + >5-fold drop in sulfonylureas—a cardiorenal/weight paradigm shift link.springer.com/article/10.1... 🔓
October 27, 2026 at 12:03 PM
tumorscholar.bsky.social
Non-invasive tests in metabolic dysfunction-associated steatotic liver disease: the LITMUS prospective multicentre diagnostic accuracy study.

#MASLD #LiverTherapy #LiverSky #Hepatology
https://doi.org/10.1016/s0140-6736(26)01145-1
Non-invasive tests in metabolic dysfunction-associated steatotic liver disease: the LITMUS prospective multicentre diagnostic accuracy study.
The advent of regulatory-approved pharmacological treatments for metabolic dysfunction-associated steatotic liver disease (MASLD) calls for precise, non-invasive biomarkers that facilitate early diagnosis, support therapy selection, and aid clinical trial enrolment. The European multicentre LITMUS s
doi.org
November 1, 2026 at 12:47 PM
sciencex.bsky.social
MRI-based elastography outperformed FibroScan at detecting advanced liver scarring. Noninvasive testing could reduce reliance on biopsies, but active inflammation remains harder to detect.
Noninvasive tests detect advanced liver scarring and could reduce reliance on biopsies
Two major international studies have delivered the strongest evidence to date on which noninvasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, reducing reliance on liver biopsy.
medicalxpress.com
October 29, 2026 at 10:30 PM
kaiodan.bsky.social
www.sciencealert.com/common-liver...
Fatty Liver Disease Is Actually Five Different Conditions, According to New Research
Metabolic dysfunction-associated steatotic liver disease (MASLD) – previously known as non-alcoholic fatty liver disease – affects around 30 percent of the global population and, as the name suggests,...
www.sciencealert.com
November 1, 2026 at 2:04 AM
perspectumltd.bsky.social
At @aasldnews.bsky.social The Liver Meeting: alone, three MRI measures identified cirrhosis in MASLD with AUCs of 0.64 to 0.72. Combined into one risk score, the AUC reached 0.86, and held at 0.83 in a separate validation group.

Poster #2422, Fri Nov 6, 1:00 PM

#Perspectum #TLM26
November 2, 2026 at 9:59 AM
scilightpress.bsky.social
🧬 Cover Article | How could nuclear receptors help tackle MASLD? This Review explores the potential of nuclear receptor-targeted therapies for metabolic dysfunction-associated steatotic liver disease.

International Journal of #Drug Discovery and #Pharmacology
doi.org/10.53941/ijd...
October 30, 2026 at 1:04 PM
kathrynmarycrowley.bsky.social
Following on from the World Health Summit in Berlin, my piece on liver health has been published. Read more here (no paywall): : kathrynmcrowley.com/stigma-and-h... #WHS2026 #liver #MASLD #health #children #obesity #Ireland
Kathryn standing in a room of people in Berlin at the World Health Summit, 2026. She is holding a laptop and wearing a wine-coloured jacket and black top.
November 2, 2026 at 5:48 PM
brainimmunity.bsky.social
University of California Riverside School of Medicine (Biomed.ucr.edu) is seeking to hire tenured Assoc or Full Professors with research programs in cardiometabolic diseases, including cardiovascular disease, type 2 diabetes, obesity, MASLD. Apply by 12/11
aprecruit.ucr.edu/JPF02370
#academicjobs
School of Medicine Division of Biomedical Sciences
Bridging the gap between science research & clinical medicine
biomed.ucr.edu
November 1, 2026 at 12:07 AM
blackpressusa.bsky.social
1/3: We need to talk about MASLD. It’s a silent condition where excess fat builds up in the liver, and it has nothing to do with alcohol consumption. @blackchronicle1 #BlackSky
Fatigue, Bloating, and Inflammation: Spotting the Subtle Signs of MASLD – BlackPressUSA
The content from the page focuses on the pressing need for awareness about MASLD (Metabolic Associated Steatotic Liver Disease), which is frequently misdiagnosed due to misconceptions that liver diseases are primarily caused by alcohol. It highlights the dangers of excess fat accumulation in the liver and correlates it with fatigue, bloating, and inflammation as subtle signs of MASLD. Furthermore, the article suggests that early diagnosis through awareness can prevent major liver damage, indicating the importance of recognizing these symptoms. Additionally, the post encourages subscribing to 'The Black Chronicle' for more in-depth articles and updates.
blackpressusa.com
October 28, 2026 at 12:10 AM
perspectumltd.bsky.social
At the @aasldnews.bsky.social Liver Meeting: in adults with hypertension, MRI found MASLD in 59% without type 2 diabetes and 73% with it. Liver and heart findings were common, but not tightly coupled.

Poster #2443, Fri Nov 6, 1:00 PM MT.

#Perspectum #TLM26 #MASLD
October 27, 2026 at 1:59 PM
medicalxpress.com.web.brid.gy
Single blood protein stands out among 30 tests for assessing fatty liver disease
The reliable assessment of metabolic dysfunction-associated steatotic liver disease (MASLD) is crucial for determining the stage of the disease, initiating appropriate treatments and monitoring the course of therapy. To date, a liver biopsy has often been necessary for this purpose. In this invasive procedure, a tissue sample is taken and examined.
medicalxpress.com
November 2, 2026 at 2:03 AM